DiviDrip · RCKT

RCKT — Rocket Pharmaceuticals, Inc.

RCKT is Rocket Pharmaceuticals, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $3.86. Market cap: $424M. Capital Quality Rank: 75/100 — Elite compounder.

Stock snapshot

Price$3.86
Market cap$424M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)75 / 100 · Elite compounder
ROIC (TTM)-32.4%
Shareholder buyback yield0.00%
Altman Z-score zoneGrey

About RCKT

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Listed2015Employees202HQNew York, NYSectorHealthcareWebsiterocketpharma.com

Related non-dividend companies

Other non-dividend stocks investors research alongside RCKT. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is RCKT's current stock price?

RCKT (Rocket Pharmaceuticals, Inc.) is currently trading at $3.86.

Does RCKT pay a dividend?

RCKT (Rocket Pharmaceuticals, Inc.) does not currently pay a regular dividend.

What is RCKT's Capital Quality Rank?

RCKT has a Capital Quality Rank of 75/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track RCKT in DiviDrip

Add RCKT to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow